close

Login

Library
Shopping Cart
Remember Me
Forgot password/Login issues?
loading animation for AJAX calls
 
 
Direct (781) 489-7301,  Toll Free (866) 285-7215

Search

Search
BCC Advance Search

BCC Research Tarceva ® Forecast

Long Term Forecasting Model for Lung Cancer Drug Tarceva ®

  • Published: May 2014
  • |
  • Product Code: FMO001A

Overview

With BCC Research's Tarceva ® Forecast, you will have quantitative data about forecasted revenue for the pharmaceutical drug Tarceva ® that will guide you in your strategic decision-making regarding future participation in this product sector.

The BCC Research Tarceva ® Forecast is a quantitative forecast model in an easily accessible Microsoft® Excel® spreadsheet, segmented by specific parameters. It features:

  • Market demand forecasts for Tarceva ® annually for the years 2010 to 2030 by volume (number of patients) and value (in U.S. dollars)
  • Segmentation of volume and value for these regions:
    • United States
    • Japan
    • Europe
    • Latin America
    • China
    • Asia
    • Middle East
  • Data transparency and sources disclosed for:
    • Patient volumes, with forecasts by causal factors including population by age range, smoker data, and prevalence, as well as for population estimates at the country level
    • Product pricing and currency valuation forecasts

Use the BCC Research Tarceva ® Forecast to:

  • Examine forecasted market demand for Tarceva ®: competitor assessment; market opportunity assessment
  • Identify new business and investment opportunities for products in the lung cancer segment
  • Validate other Tarceva ® market-demand data to which you have access

Tarceva ® is a once-daily, oral, non-chemotherapy prescription drug for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC).  Some clinical studies have shown superior patient outcomes from use of Tarceva ® as a second-line treatment for NSCLC. Tarceva ® begins to fall outside of patent protection in numerous countries starting in 2020.

Tarceva ® is a registered trademark of OSI Pharmaceuticals. Microsoft and Excel are registered trademarks of Microsoft Corporation.

TABLE OF CONTENT

Figure 1 Summary Graphs - Value in U.S.D. and Patient Volumes, by Region, 2010-2030

Table 1 Total Market - Value in U.S.D. and Patient Volumes, by Region, 2010-2030

Table 2 United States Patient Volumes, 2010-2030

Table 3 Europe Patient Volumes, 2010-2030

Table 4 Japan Patient Volumes, 2010-2030

Table 5 China Patient Volumes, 2010-2030

Table 6 Asia Patient Volumes, 2010-2030

Table 7 Africa/Oceania Patient Volumes, 2010-2030

Table 8 Middle East Patient Volumes, 2010-2030

Table 9 Americas Patient Volumes, 2010-2030

Table 10 United States Population by age range, 2010-2030

Table 11 Europe Population by Country, 2010-2030

Table 12 Japan Population, 2010-2030

Table 13 China Population, 2010-2030

Table 14 Asia Population by Country, 2010-2030

Table 15 Africa/Oceania Population by Country, 2010-2030

Table 16 Middle East Population by Country, 2010-2030

Table 17 Americas Population by Country, 2010-2030

Table 18 United States Smoker Data

Table 19 Europe Smoker Data by Country

Table 20 Japan Smoker Data

Table 21 China Smoker Data

Table 22 Asia Smoker Data by Country

Table 23 Africa/Oceania Smoker Data by Country

Table 24 Middle East Smoker Data by Country

Table 25 Americas Smoker Data by Country

Table 26 United States Lung Cancer Data, 1975-2010

Table 27 Global Lung Cancer Data, by Male and Female, by Region

Table 28 United States Pricing, Tarceva Annual Cost

Table 29 Europe Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

Table 30 Japan Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

Table 31 China Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

Table 32 Asia Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

Table 33 Africa/Oceania Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

Table 34 Middle East Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

Table 35 Americas Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

SPECIAL OFFER - Price $5000 $3000

Pricing on the website is provided for single users and 2-5 users licenses only. Please contact us at (+1)781-489-7301 or send an email to information@bccresearch.com to purchase multi-user licenses.
  Title/Chapter Name Pages Price
BCC Research Tarceva ® Forecast $5000
Chapter- 1: Introduction - Complimentary $0
  Show Details
 
Recommended combos for Tarceva®
Special Offer! You can purchase your choice of any BCC Research report + the Tarceva® Forecast Model [Single User License] for $8000.

BCC Market Forecast: Tarceva®

Price: $5000

+

Any BCC Research Report

Price: $6650

=

Total Price: $11650

Combo Price: $8000

Discount will be applied automatically after you will add the forecast model and any report to your cart.

 
Select License type:
download sample chapter download table of contents
Want to find out more
about this report?